romiplostim ITP
Selected indexed studies
- Efficacy of romiplostim in the treatment of ITP in children: a meta-analysis. (Eur Rev Med Pharmacol Sci, 2018) [PMID:30280805]
- Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment. (Blood Rev, 2024) [PMID:38942688]
- A Review of Romiplostim Mechanism of Action and Clinical Applicability. (Drug Des Devel Ther, 2021) [PMID:34079225]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A Review of Romiplostim Mechanism of Action and Clinical Applicability. (2021) pubmed
- Romiplostim. (2011) pubmed
- Romiplostim. (2009) pubmed
- Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment. (2024) pubmed
- Thrombopoietin receptor agonists: ten years later. (2019) pubmed
- Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management. (2024) pubmed
- Efficacy of romiplostim in the treatment of ITP in children: a meta-analysis. (2018) pubmed
- Experts' review: the emerging roles of romiplostim in immune thrombocytopenia (ITP). (2021) pubmed
- Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. (2008) pubmed
- The 'Stop TPO-RA in ITP Patients' study: Clinical and immune modulatory effects of romiplostim tapering. (2025) pubmed